Morbidity and cost of rotavirus infections in France;Morbidité et coût des infections à rotavirus en France

Medecine et Maladies Infectieuses

Volumn 35, Issue 10, 2005, Pages 492-499

  Melliez, H ^a   Boelle, P Y ^b   Baron, S ^c   Mouton, Y ^a   Yazdanpanah, Y ^a,d,e  

^a UNIV LILLE   (France)

^b INSERM   (France)

^c Département d'Information Médicale et d'Épidé miologie   (France)

^d UNIV LILLE   (France)

^e CNRS   (France)

Author keywords

Acute diarrhea; Markov model; Rotavirus

Indexed keywords

ARTICLE; BREAST FEEDING; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEATH; DECISION MAKING; DIARRHEA; FRANCE; GENERAL PRACTITIONER; HEALTH PROGRAM; HOSPITALIZATION; INCIDENCE; MORBIDITY; MORTALITY; ROTAVIRUS; VACCINATION; VIRUS INFECTION;

CHILD, PRESCHOOL; COHORT STUDIES; COSTS AND COST ANALYSIS; DECISION TREES; DIARRHEA; FAMILY PRACTICE; FRANCE; HUMANS; INFANT; INPATIENTS; MORBIDITY; ROTAVIRUS INFECTIONS;

EID: 28844459626     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.08.007     Document Type: Article

References (42)

1. G.P. Davidson, R.F. Bishop, R.R. Townley, and I.H. Holmes Importance of a new virus in acute sporadic enteritis in children Lancet 1 7901 1975 242 246
2. J.C. Desenclos, I. Rebiere, L. Letrillard, A. Flahault, and B. Hubert Diarrhoea-related morbidity and rotavirus infection in France Acta. Paediatr. Suppl 1999 42 47 (Sect)
3. F. Moulin, E. Marc, M. Lorrot, S. Coquery, H. Sauve-Martin, and S. Ravilly Hospitalization for acute community-acquired rotavirus gastroenteritis: a 4:years survey Arch. Pediatr. 9 3 2002 255 261
4. E. Grimprel, N. Parez, E. Gault, A. Garbarg-Chenon, and P. Begue Acute diarrhea and rotavirus infection in the child: assessment of data from emergency care and the microbiology laboratory of the Armand-Trousseau (Paris) hospital between 1988 and 2001 Arch. Pediatr. 8 12 2001 1318 1324
5. A. Marie-Cardine, K. Gourlain, O. Mouterde, N. Castignolles, M.F. Hellot, and E. Mallet Epidemiology of acute viral gastroenteritis in children hospitalized in Rouen, France Clin. Infect. Dis. 34 9 2002 1170 1178
6. A. Martinot, C. Lejeune, V. Hue, C. Fourier, C. Beyaert, and J.F. Diependaele Modality and causes of 259 deaths in a pediatric intensive care unit Arch. Pediatr. 2 8 1995 735 741
7. R. Chikhi-Brachet, F. Bon, L. Toubiana, P. Pothier, J.C. Nicolas, and A. Flahault Virus diversity in a winter epidemic of acute diarrhea in France J. Clin. Microbiol. 11 40 2002 4266 4272
8. M. Koopmans, and D. Brown Seasonality and diversity of group A rotaviruses in Europe Acta Paediatr. Suppl. 88 426 1999 14 19
9. F. Bon, C. Fromantin, S. Aho, P. Pothier, and E. Kohli G and P genotyping of rotavirus strains circulating in France over a three-year period: detection of G9 and P[6] strains at low frequencies. The AZAY Group J. Clin. Microbiol. 38 4 2000 1681 1683
10. E. Gault, R. Chikhi-Brachet, S. Delon, N. Schnepf, L. Albiges, and E. Grimprel Distribution of human rotavirus G types circulating in Paris, France, during the 1997-1998 epidemic: high prevalence of type G4 J. Clin. Microbiol. 37 7 1999 2373 2375
11. R.F. Bishop, G.L. Barnes, E. Cipriani, and J.S. Lund Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children N. Engl. J. Med. 309 2 1983 72 76
12. J.Z. Mrukowicz, J. Thompson, G.W. Reed, S.J. Tollefson, M. Kobayashi, and K. Araki Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination Vaccine 17 7-8 1999 745 753
13. F.R. Velazquez, D.O. Matson, J.J. Calva, L. Guerrero, A.L. Morrow, and S. Carter-Campbell Rotavirus infections in infants as protection against subsequent infections N. Engl. J. Med. 335 14 1996 1022 1028
14. R.L. Ward, and D.I. Bernstein Protection against rotavirus disease after natural rotavirus infection. US Rotavirus vaccine efficacy group J. Infect. Dis. 169 4 1994 900 904
15. T.V. Murphy, P.M. Gargiullo, M.S. Massoudi, D.B. Nelson, A.O. Jumaan, and C.A. Okoro Intussusception among infants given an oral rotavirus vaccine N. Engl. J. Med. 344 8 2001 564 572
16. D.I. Bernstein, V.E. Smith, J.R. Sherwood, G.M. Schiff, D.S. Sander, and D. DeFeudis Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12 Vaccine 16 4 1998 381 387
17. D.I. Bernstein, D.A. Sack, E. Rothstein, K. Reisinger, V.E. Smith, and D. O'Sullivan Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial Lancet 354 9175 1999 287 290
18. D.I. Bernstein, D.A. Sack, K. Reisinger, E. Rothstein, and R.L. Ward Second-year follow-up evaluation of live, attenuated human rotavirus vaccine 89-12 in healthy infants J. Infect. Dis. 186 10 2002 1487 1489
19. M.L. Clements-Mann, R. Dudas, Y. Hoshino, P. Nehring, E. Sperber, and M. Wagner Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants Vaccine 19 32 2001 4676 4684
20. L. Doisneau Bilan d́mographique 2001 2002 INSEE
21. M. Gurwith, W. Wenman, D. Hinde, S. Feltham, and H. Greenberg A prospective study of rotavirus infection in infants and young children J. Infect. Dis. 144 3 1981 218 224
22. W.J. Rodriguez, H.W. Kim, C.D. Brandt, R.H. Schwartz, M.K. Gardner, and B. Jeffries Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations Pediatr. Infect. Dis. J. 6 2 1987 170 176
23. T. Ruuska, and T. Vesikari A prospective study of acute diarrhoea in Finnish children from birth to 2 1/2:years of age Acta Paediatr. Scand. 80 5 1991 500 507
24. D. Sethi, P. Cumberland, M.J. Hudson, L.C. Rodrigues, J.G. Wheeler, and J.A. Roberts A study of infectious intestinal disease in England: risk factors associated with group A rotavirus in children Epidemiol. Infect. 126 1 2001 63 70
25. P. Gianino, E. Mastretta, P. Longo, A. Laccisaglia, M. Sartore, and R. Russo Incidence of nosocomial rotavirus infections, symptomatic and asymptomatic, in breast-fed and non-breast-fed infants J. Hosp. Infect. 50 1 2002 13 17
26. T. Ruuska, and T. Vesikari Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes Scand. J. Infect. Dis. 22 3 1990 259 267
27. A.K. Takala, E. Koskenniemi, J. Joensuu, M. Makela, and T. Vesikari Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine Clin. Infect. Dis. 27 2 1998 272 282
28. J. Joensuu, E. Koskenniemi, X.L. Pang, and T. Vesikari Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis Lancet 350 9086 1997 1205 1209
29. T. Vesikari, T. Ruuska, K.Y. Green, J. Flores, and A.Z. Kapikian Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity Pediatr. Infect. Dis. J. 11 7 1992 535 542
30. T. Ruuska, T. Vesikari, A. Delem, F.E. Andre, G.M. Beards, and T.H. Flewett Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period Scand. J. Infect. Dis. 22 3 1990 269 278
31. A. Martinot, A. Dumonceaux, B. Grandbastien, V. Hue, and F. Leclerc Evaluation of the ambulatory treatment of acute diarrhea in infants. Ŕseau interhospitalier d'evaluation des pratiques ḿdicales dans les affections courantes de l'enfant Arch. Pediatr. 4 9 1997 832 838
32. French general practitioners' Sentinelles network. http://www.u444. jussieu.fr/sentiweb. In; 2003.
33. D.I. Bernstein, R.I. Glass, G. Rodgers, B.L. Davidson, and D.A. Sack Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus vaccine efficacy group JAMA 273 15 1995 1191 1196
34. A.M. Hoogenboom-Verdegaal, J.C. de Jong, M. During, R. Hoogenveen, and J.A. Hoekstra Community-based study of the incidence of gastrointestinal diseases in The Netherlands Epidemiol. Infect. 112 3 1994 481 487
35. F. Fourquet, J.C. Desenclos, C. Maurage, and S. Baron Acute gastroenteritis in children in France: estimates of disease burden through national hospital discharge data Arch. Pediatr. 10 10 2003 861 868
36. Officiel J. www.journal-officiel.gouv.fr. In; 2003.
37. M.C. Weinstein, J.E. Siegel, M.R. Gold, M.S. Kamlet, and L.B. Russell Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 15 1996 1253 1258
38. T. Vesikari, T. Rautanen, T. Varis, G.M. Beards, and A.Z. Kapikian Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age Am. J. Dis. Child. 144 3 1990 285 289
39. M.B. Rennels, G.A. Losonsky, A.E. Young, C.L. Shindledecker, A.Z. Kapikian, and M.M. Levine An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group Am. J. Dis. Child. 144 5 1990 601 604
40. M. Santosham, L.H. Moulton, R. Reid, J. Croll, R. Weatherholt, and R. Ward Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in native American populations J. Pediatr. 131 4 1997 632 638
41. A.W. Tucker, A.C. Haddix, J.S. Bresee, R.C. Holman, U.D. Parashar, and R.I. Glass Cost-effectiveness analysis of a rotavirus immunization program for the United States JAMA 279 17 1998 1371 1376
42. DeVos A Rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis Pediatr. Infect. Dis. J. 23 2004 S179 S182